Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-Hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison-Reference-Cited by-同舟云学术

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-Hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Published:2001-03 Issue:3 Volume:37 Page:532-543
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Maung Hla M.,Elangovan Loganathan,Frazão João M.,Bower John D.,Kelley Bobby J.,Acchiardo Sergio R.,Rodriguez Hector J.,Norris Keith C.,Sigala Jerald F.,Rutkowski Mark,Robertson John A.,Goodman William G.,Levine Barton S.,Chesney Russell W.,Mazess Richard B.,Kyllo Darlene M.,Douglass Laura L.,Bishop Charles W.,Coburn Jack W.

Publisher

Elsevier BV

Subject

Nephrology

Reference19 articles.

1. Effective suppression of parathyroid hormone by 1α-hydroxyvitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism;Tan;Kidney Int,1997

2. Intermittent doxercalciferol (1α-hydroxyvitamin D2 ) therapy for secondary hyperparathyroidism: Results of a modified, double-blinded, controlled study;Frãzão;Am J Kidney Dis,2000

3. Efficacy and safety of intermittent oral 1α (OH)-vitamin D2 in suppressing 2o hyperparathyroidism in hemodialysis patients;Frãzão;Dial Transplant,1997

4. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients;Slatopolsky;J Clin Invest,1984

5. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism;Fischer;Clin Nephrol,1993

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism;Annals of Surgery;2022-07-18

2. Calcium, phosphate, PTH, vitamin D, and FGF-23 in CKD-mineral and bone disorder;Nutritional Management of Renal Disease;2022

3. Mineral Bone Disorders in Chronic Kidney Disease;Chronic Kidney Disease, Dialysis, and Transplantation;2019

4. Utilisation de l’alfacalcidol et des analogues actifs de la vitamine D dans la maladie rénale chronique;Néphrologie & Thérapeutique;2018-06

5. CYP24A1;Vitamin D;2018